Ayurvedic, Siddha, and Unani medicine manufacturers must meet specific regulatory requirements before producing medicines commercially in West Bengal. Two requirements often create confusion: an AYUSH manufacturing licence and Good Manufacturing Practices certification. Although both relate to regulatory compliance, they serve different purposes.
A manufacturing licence grants legal permission to manufacture specified products, while GMP requirements focus on manufacturing quality, hygiene, premises, equipment, documentation, and process controls. Businesses must distinguish these requirements before planning a manufacturing unit, filing applications, arranging facilities, or preparing for regulatory inspection.
What Is an AYUSH Manufacturing License?
An AYUSH manufacturing licence provides regulatory permission to manufacture Ayurvedic, Siddha, or Unani medicines covered by applicable drug laws. Manufacturers cannot treat this permission as a general business registration because drug manufacturing attracts specialised statutory controls.
The Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945 contain important provisions governing Ayurvedic, Siddha, and Unani medicines. Consequently, manufacturers must satisfy applicable requirements relating to premises, technical personnel, manufacturing arrangements, product details, records, labelling, and quality control.
An AYUSH license in West Bengal therefore forms a fundamental legal requirement for businesses intending to manufacture regulated traditional medicines within the state.
Moreover, the licence generally connects the approved manufacturing facility with authorised categories or products. Businesses must consequently avoid assuming that obtaining one permission automatically authorises every formulation, dosage form, or manufacturing activity.
What Does the License Legally Permit?
The permission allows an eligible manufacturer to conduct approved manufacturing activities subject to licence conditions and applicable regulations. However, manufacturers must continue meeting those conditions after receiving approval.
The licensing process commonly evaluates:
- Constitution and identity of the applicant
- Legal possession of manufacturing premises
- Suitability of manufacturing areas
- Required machinery and equipment
- Technical staff qualifications
- Quality-control arrangements
- Product and formulation information
- Record-maintenance systems
- Applicable GMP requirements
- Labelling and packaging compliance
Consequently, obtaining approval represents the beginning of continuing regulatory responsibility rather than the end of compliance.
What Is GMP Certification for AYUSH Medicines?
Good Manufacturing Practices establish operational and facility standards that manufacturers must follow to produce medicines consistently under controlled conditions. For Ayurvedic, Siddha, and Unani medicines, Schedule T of the Drugs and Cosmetics Rules contains important GMP requirements.
GMP focuses heavily on how manufacturers organise premises, people, processes, sanitation, equipment, raw materials, quality controls, documentation, and finished-product handling.
In contrast to basic business permissions, GMP requirements address the manufacturing environment itself. Regulators expect manufacturers to create systems that reduce contamination risks, prevent mix-ups, maintain traceability, support consistent quality, and ensure proper storage.
Major Areas Covered by GMP Requirements
A compliant manufacturing facility normally needs controls covering several operational areas. Depending on products and activities, relevant considerations may include:
- Location and surroundings
- Building design and maintenance
- Water supply
- Waste disposal
- Storage arrangements
- Raw-material handling
- Manufacturing equipment
- Cleaning procedures
- Production records
- Quality-control facilities
- Personnel hygiene
- Finished-goods storage
- Complaint handling
- Product recall procedures
Moreover, manufacturers should maintain these controls continuously. A facility that meets standards during inspection but later neglects documentation, sanitation, equipment maintenance, or quality procedures may create serious compliance risks.
AYUSH License vs GMP Certification: Core Difference
The most important distinction lies in regulatory purpose. An AYUSH manufacturing licence authorises manufacturing activities, whereas GMP compliance demonstrates that the manufacturing establishment follows prescribed quality-oriented practices and facility standards.
Consequently, businesses should not treat the two requirements as interchangeable.
Legal Permission Versus Manufacturing Standards
The manufacturing licence answers a fundamental regulatory question: whether the establishment has permission to manufacture the approved medicines.
GMP requirements address another question: whether the establishment maintains appropriate manufacturing conditions and quality systems.
Therefore, a business cannot normally rely on GMP compliance alone as legal authority to manufacture medicines. Similarly, possession of a manufacturing licence does not permit a manufacturer to disregard continuing GMP obligations.
Moreover, regulatory authorities may examine both dimensions during scrutiny and inspection. Applicants should therefore prepare licensing documents and physical manufacturing arrangements together rather than treating them as unrelated projects.
Why Both Requirements Matter for Manufacturers
Traditional medicine manufacturing involves raw herbs, minerals where permitted, extracts, powders, oils, tablets, syrups, semisolid preparations, and other dosage forms. Each manufacturing activity can create distinct quality and contamination risks.
Consequently, regulators require structured manufacturing controls alongside legal authorisation.
A licensing framework helps authorities identify manufacturers, approved premises, technical personnel, and permitted manufacturing activities. Meanwhile, GMP requirements establish operating conditions intended to support consistent manufacturing quality.
Commercial Importance of Proper Compliance
Regulatory compliance also affects ordinary commercial operations. Proper approvals can influence distributor onboarding, institutional procurement, contract manufacturing relationships, product expansion, and regulatory inspections.
Moreover, organised documentation allows businesses to respond efficiently when authorities request production records, testing information, raw-material details, or manufacturing documents.
Manufacturers should therefore view licensing and GMP controls as connected components of a wider compliance system. Weakness in either area can interrupt production and create avoidable regulatory exposure.
Eligibility Considerations Before Applying
Before filing an application, promoters should assess whether the proposed facility, technical team, products, and business structure satisfy applicable requirements.
The applicant should first establish a lawful business entity or operating structure. Additionally, the applicant must secure suitable premises and demonstrate lawful possession through appropriate documents.
Technical and Operational Readiness
Manufacturing operations require appropriately qualified technical personnel as prescribed for relevant activities. Therefore, businesses should verify educational qualifications, experience requirements where applicable, appointment documents, and availability before submission.
Applicants should also evaluate:
- Proposed medicine categories
- Dosage forms to be manufactured
- Required manufacturing sections
- Machinery requirements
- Quality-control arrangements
- Raw-material storage capacity
- Finished-product storage
- Sanitation facilities
- Recordkeeping procedures
- Waste-management arrangements
Consequently, early planning can prevent expensive alterations after an inspection identifies structural or operational shortcomings.
Premises Requirements and Facility Planning
Facility planning directly affects both licensing and GMP readiness. Manufacturers should arrange premises according to the nature and scale of manufacturing operations rather than adapting an unsuitable building after filing.
Different activities may require separated or properly controlled manufacturing spaces. Moreover, the layout should support orderly movement of raw materials, personnel, intermediate products, packaging materials, and finished medicines.
Key Facility Considerations
Manufacturers should pay particular attention to:
- Adequate manufacturing space
- Cleanable floors and surfaces
- Ventilation and lighting
- Pest-control arrangements
- Proper drainage
- Safe water supply
- Segregated storage
- Equipment placement
- Cleaning areas
- Quality-control arrangements
- Toilets positioned appropriately
- Waste collection and disposal
Furthermore, premises should reduce contamination and cross-contamination risks. A logical layout also supports inspections because officers can assess manufacturing flow, storage controls, sanitation, and equipment more efficiently.
Machinery and Equipment Requirements
Equipment requirements depend on the proposed dosage forms and manufacturing processes. A manufacturer producing oils may require different machinery from a unit producing tablets, powders, syrups, or ointments.
Therefore, applicants should match machinery with actual manufacturing activities instead of purchasing generic equipment merely to complete an application.
Equipment Control After Approval
Installing machinery alone does not establish effective GMP compliance. Manufacturers should maintain equipment appropriately, clean it according to written procedures, and preserve relevant maintenance or usage records.
Moreover, equipment should not create contamination risks or compromise product quality. Suitable placement should permit cleaning, inspection, maintenance, and orderly manufacturing.
Consequently, manufacturers should incorporate equipment management into standard operating procedures and staff responsibilities.
Quality Control and Testing Arrangements
Quality control plays a central role in traditional medicine manufacturing. Raw materials can vary naturally, so manufacturers need appropriate procedures for identification, acceptance, storage, processing, and testing.
Finished medicines must also meet applicable quality requirements. Therefore, businesses should establish suitable testing arrangements and maintain required records.
Documentation Supporting Quality Control
Important records may include:
- Raw-material specifications
- Supplier details
- Receipt records
- Sampling records
- Testing reports
- Batch manufacturing records
- Finished-product specifications
- Release records
- Rejection records
- Storage records
- Complaint documentation
Moreover, traceable records help establish what materials entered a batch, how employees processed them, and what quality checks occurred before release.
Documents Commonly Required for Licensing
Document requirements can vary according to application type, manufacturing arrangement, product category, and regulatory directions. Applicants should therefore verify the current requirements before submission.
Nevertheless, manufacturers commonly prepare documents relating to business identity, premises, technical staff, manufacturing facilities, products, and quality systems.
Typical Application Documentation
A licensing file may contain:
- Applicant constitution documents
- Identity and address records
- Premises ownership or occupancy documents
- Site and layout plans
- Machinery and equipment lists
- Technical personnel documents
- Qualification certificates
- Appointment records
- Product formulation details
- Manufacturing process information
- Quality-control arrangements
- Applicable declarations
- Fee payment evidence
- Supporting regulatory permissions
Furthermore, inconsistent names, addresses, measurements, or product details across documents can delay scrutiny. Applicants should therefore conduct a document-level consistency review before filing.
Role of Inspection in Licensing and GMP Compliance
Inspection allows regulatory officers to compare application claims with actual conditions at the manufacturing premises. Consequently, businesses should prepare the operational facility rather than relying solely on paperwork.
Inspecting officers may examine manufacturing sections, equipment, storage, sanitation, technical personnel, documentation, quality-control arrangements, and other applicable requirements.
Preparing for Regulatory Inspection
Before inspection, manufacturers should check whether:
- Installed machinery matches submitted details
- Manufacturing sections remain properly organised
- Technical personnel remain available
- Raw-material storage follows proper controls
- Cleaning records remain current
- Required registers remain accessible
- Quality systems operate as documented
- Labels and product documents remain consistent
- Waste-management arrangements function properly
Moreover, employees responsible for manufacturing and quality functions should know their assigned duties. Clear responsibilities reduce confusion and demonstrate functional compliance.
Can a Business Obtain GMP Without an AYUSH License?
Businesses should distinguish a facility’s compliance preparations from legal manufacturing authority. A proposed unit can design premises and systems according to GMP standards before receiving its manufacturing licence. Indeed, applicants often need substantial GMP readiness before inspection.
However, meeting facility standards does not independently authorise commercial manufacture of regulated Ayurvedic, Siddha, or Unani medicines.
Consequently, promoters should avoid beginning unauthorised manufacturing merely because the premises appear GMP compliant. Legal manufacturing should start only after obtaining the permissions required for the proposed activity.
Can an AYUSH License Exist Without Continuing GMP Compliance?
A licence holder must continue satisfying applicable licence conditions and manufacturing standards. Therefore, compliance cannot stop once authorities grant permission.
If a facility later develops sanitation failures, poor documentation, unsuitable storage, equipment problems, or quality-control deficiencies, regulators may require corrective action and may take other action available under applicable law.
Moreover, manufacturing businesses should conduct periodic internal reviews. Such reviews help identify gaps before regulatory inspections or product-quality issues expose them.
Common Compliance Mistakes Manufacturers Should Avoid
Many licensing delays arise from preventable inconsistencies between documents, premises, staffing, equipment, and proposed products. Consequently, manufacturers should conduct a coordinated review before filing.
Common problems include:
- Selecting unsuitable premises
- Filing incomplete layout details
- Appointing ineligible technical personnel
- Installing insufficient machinery
- Providing inconsistent product information
- Ignoring storage requirements
- Maintaining weak sanitation controls
- Keeping incomplete batch records
- Neglecting equipment maintenance
- Using inadequate quality-control procedures
- Making unapproved changes
- Ignoring post-licence compliance
Moreover, manufacturers should avoid copying another facility’s documentation without adapting procedures to their own operations. Every manufacturing unit has specific products, equipment, workflow, staffing, and quality risks.
Product Approval and Formulation Considerations
Manufacturing permission does not remove the need to evaluate individual formulations carefully. Businesses should classify proposed medicines correctly and prepare product documentation according to applicable legal requirements.
Ingredients, dosage forms, textual references where relevant, manufacturing processes, indications, and labelling require careful regulatory review.
Why Product Classification Matters
Incorrect classification can affect the documentation and regulatory route applicable to a product. Consequently, businesses should finalise formulations before preparing licensing submissions.
Moreover, manufacturers should avoid changing ingredients, claims, dosage forms, or manufacturing processes casually after approval. Where a change requires regulatory permission, the business should complete the prescribed process before implementing it commercially.
Labelling and Packaging Compliance
Packaging protects medicines from contamination, deterioration, and handling damage. Meanwhile, labels communicate legally significant product information.
Manufacturers should therefore verify applicable labelling requirements before printing large quantities of packaging material.
Depending on the medicine and applicable provisions, labels may need prescribed particulars relating to the product, manufacturer, batch, manufacturing licence, dates, ingredients, quantity, directions, warnings, or other mandatory information.
Consequently, businesses should align approved product information with packaging artwork. Even a properly manufactured medicine can face compliance issues when its label contains inaccurate, incomplete, misleading, or unauthorised information.
Post-License Compliance Responsibilities
Regulatory responsibility continues throughout commercial operations. Manufacturers should maintain systematic records and monitor changes affecting premises, personnel, products, machinery, ownership, or manufacturing arrangements.
Moreover, businesses should track applicable renewal, retention, modification, notification, or approval requirements relevant to their licences.
Internal Compliance Controls
A practical internal system should assign responsibility for:
- Licence records
- GMP documentation
- Batch records
- Testing documentation
- Technical staff records
- Equipment maintenance
- Cleaning schedules
- Complaint handling
- Product recalls
- Regulatory correspondence
- Change management
- Inspection preparation
Consequently, centralised compliance management can reduce missed deadlines and conflicting records.
How Manufacturers Should Choose Their Compliance Approach?
Businesses do not need to choose between licensing and GMP compliance because the requirements perform different regulatory functions. Instead, promoters should build both into the same establishment plan.
First, determine the proposed products and manufacturing activities. Next, identify premises, equipment, staffing, testing, and documentation requirements. Then, align the physical facility with GMP standards while preparing the licensing application.
Moreover, businesses should review the facility against submitted documents before inspection. This coordinated approach reduces the possibility that paperwork describes arrangements that inspectors cannot verify physically.
Practical Steps for Better Application Readiness
A structured preparation process can reduce avoidable objections and operational delays.
Manufacturers should:
- Finalise the business structure and manufacturing model.
- Identify proposed medicine categories and dosage forms.
- Select legally suitable manufacturing premises.
- Prepare an accurate facility layout.
- Install appropriate machinery and equipment.
- Appoint eligible technical personnel.
- Establish quality-control arrangements.
- Implement GMP-focused operating procedures.
- Prepare product and formulation documentation.
- Review labels and packaging requirements.
- Compile licensing documents consistently.
- Conduct an internal pre-inspection review.
- Address deficiencies before regulatory inspection.
- Maintain compliance after receiving approval.
Consequently, manufacturers can treat regulatory preparation as an integrated operational project rather than a paperwork exercise.
Conclusion
AYUSH manufacturing licensing and GMP certification address different but closely connected regulatory responsibilities in West Bengal. The licence establishes legal authority for approved manufacturing, while GMP requirements support controlled, hygienic, documented, and quality-focused production. Consequently, manufacturers should integrate premises planning, technical staffing, machinery, quality control, product documentation, labelling, and recordkeeping from the beginning. Proper coordination reduces application deficiencies and strengthens continuing compliance. Businesses should also monitor regulatory conditions after approval because maintaining compliant manufacturing systems remains essential throughout commercial operations.
FAQs
1. Is an AYUSH manufacturing license the same as GMP certification?
No. A manufacturing licence provides legal permission for approved manufacturing activities, while GMP requirements govern manufacturing conditions and quality systems. However, the two remain closely connected because regulators assess manufacturing standards when determining whether a facility satisfies applicable requirements. Manufacturers should therefore prepare for both licensing and continuing GMP compliance.
2. Is GMP mandatory for Ayurvedic medicine manufacturers?
Applicable Ayurvedic, Siddha, and Unani drug manufacturers must comply with prescribed manufacturing standards, including relevant Schedule T requirements. Consequently, businesses should design premises, equipment, sanitation, documentation, quality control, and operating procedures around applicable GMP obligations before inspection rather than attempting to correct fundamental facility deficiencies after filing.
3. Can I manufacture Ayurvedic medicines after receiving only GMP approval?
GMP compliance by itself should not be treated as legal authority to manufacture regulated medicines commercially. Manufacturers need the applicable manufacturing permission for their activities. Therefore, promoters should complete the required licensing process and satisfy associated regulatory conditions before starting commercial production of medicines covered by the relevant statutory framework.
4. What does an AYUSH GMP inspection usually examine?
An inspection may cover premises, manufacturing areas, machinery, sanitation, storage, technical personnel, quality-control arrangements, records, raw-material handling, finished products, and other applicable requirements. Moreover, inspectors may compare physical arrangements with submitted application details. Manufacturers should keep facilities operationally ready and maintain accurate, accessible documentation.
5. Does every AYUSH product require the same machinery?
No. Machinery depends significantly on dosage form, manufacturing process, production scale, and product category. For example, manufacturing powders involves different equipment from producing oils or liquid preparations. Consequently, applicants should prepare machinery lists around their proposed manufacturing activities and ensure installed equipment corresponds with application information.
6. Why are batch manufacturing records important?
Batch records create traceability throughout production. They can document materials, quantities, processing stages, responsible personnel, dates, and relevant manufacturing controls. Moreover, reliable records help investigate complaints, deviations, or quality concerns. Manufacturers should complete records contemporaneously and preserve them according to applicable regulatory and internal document-control requirements.
7. Can a manufacturer change premises after receiving the license?
A manufacturer should not assume that an existing licence automatically covers a different manufacturing location. A premises change can trigger regulatory procedures, inspections, amendments, or fresh permissions depending on applicable requirements. Consequently, businesses should obtain necessary regulatory clearance before shifting licensed manufacturing operations or making significant facility changes.
8. What happens if a facility fails GMP requirements?
Regulatory authorities may identify deficiencies and require corrective measures according to applicable law and circumstances. Serious or continuing non-compliance can create licensing and operational consequences. Therefore, manufacturers should address inspection observations promptly, document corrective actions, improve internal controls, and prevent repeated failures through systematic compliance monitoring.
9. Are quality-control arrangements necessary for AYUSH manufacturing?
Quality control remains an important part of regulated manufacturing because manufacturers must control raw materials, production processes, and finished medicines. Appropriate testing and documentation support product consistency and regulatory compliance. Consequently, businesses should establish suitable quality-control arrangements based on their products, processes, applicable standards, and statutory requirements.
10. Which should a manufacturer prepare first: licensing or GMP?
Manufacturers should prepare them together. Licensing documentation depends partly on premises, equipment, staff, products, and quality arrangements, while GMP readiness requires those operational elements to function properly. Therefore, businesses should develop the facility and compliance documentation simultaneously, conduct internal checks, correct gaps, and then proceed through the applicable regulatory process.
